New York Headache Center
New York Headache Center is a Manhattan-based, founder-owned neurology practice founded in 1987 that provides integrative headache and migraine treatment to adults and children, combining FDA-approved procedures (Botox, IV therapies, TMS) with complementary therapies, serving U.S. and international patients from over 30 countries.
- Company typePrivate
- Founded1987
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What New York Headache Center does
New York Headache Center (NYHC), founded in 1987 by Dr. Alexander Mauskop, is a single-site, specialty neurology practice headquartered at 30 East 76th Street in Manhattan. The practice is structured as a privately held, founder-owned medical clinic with 7-9 staff, including two board-certified neurologists (Dr. Mauskop, Dr. Sara Crystal, Dr. Britany Klenofsky), two nurse practitioners, an Administrative Director, and a Director of Operations & Revenue Cycle. NYHC treats adults and children with chronic and episodic migraines, tension-type, cluster, and cervicogenic headaches, serving both U.S. patients and an international patient base from over 30 countries.
NYHC's core offering is integrative headache medicine that combines FDA-approved conventional neurology treatments with functional, complementary, and alternative therapies. Procedure-based services include Botox injections for chronic migraine (using a 31-site, 155-unit FDA-approved protocol pioneered at NYHC since 1992), intravenous magnesium and other IV therapies (e.g., ketorolac, DHE-45, Vyepti), sphenopalatine ganglion (SPG) nerve blocks, and Transcranial Magnetic Stimulation (TMS) guided by fMRI. The center also offers biofeedback, meditation, and nutritional supplement regimens, with a particular focus on pediatric headache care and non-opioid alternatives. Beyond clinical care, the practice runs the NYHC Educational Symposia program, which has trained 200+ physicians in advanced headache techniques.
NYHC generates revenue primarily through fee-for-service medical consultations, in-office procedures, and insurance/self-pay billing, supplemented by royalties from Dr. Mauskop's published books including the Amazon best-seller 'The End of Migraines: 150 Ways to Stop Your Pain' (editions in 2021, 2022, 2026) and two Oxford University Press medical textbooks. Patient acquisition is driven almost entirely by Dr. Mauskop's personal brand, scientific publications (reviewer for NEJM, Neurology, Headache journals), media appearances (PBS, Vogue, O Magazine), peer referrals, and the practice's blog and Substack newsletter. Telemedicine consultations extend the practice's reach to U.S. patients, while international patients travel to the Manhattan office.
New York Headache Center firmographics
Firmographics- Name
- New York Headache Center
- Legal name
- New York Headache Center
- Website
- https://nyheadache.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- New York Headache Center is a Manhattan-based, founder-owned neurology practice founded in 1987 that provides integrative headache and migraine treatment to adults and children, combining FDA-approved procedures (Botox, IV therapies, TMS) with complementary therapies, serving U.S. and international patients from over 30 countries.
- Ownership category
- akta.pro rank
New York Headache Center industry classification
Industry- Product category
- Specialty Neurology / Headache Medicine Services
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Headache & Migraine Medicine (HLAKAIAE)
- akta.pro secondary industries
- Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Pain Management Clinics (Interventional & Medical) (HLAFABAH)
Keywords
Where New York Headache Center is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
New York Headache Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Consultation and Treatment Services: The primary revenue stream is fee-for-service medical care including consultations, in-office procedures (Botox injections, nerve blocks, IV therapies), and follow-up visits. Services are billed to insurance and/or patients directly.
- Book Sales and Publications: Dr. Mauskop earns royalties from published books including 'The End of Migraines: 150 Ways to Stop Your Pain' (multiple editions on Amazon), and two medical textbooks published by Oxford University Press.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
New York Headache Center product offering
Product offeringCore offering
New York Headache Center provides specialized medical care for the diagnosis and treatment of headaches and migraines in children and adults, offering integrative, non-opioid solutions including Botox injections, IV infusions, TMS, nerve blocks, and complementary therapies delivered at its Manhattan office and via telemedicine.
Product overview
New York Headache Center is a medical practice led by Dr. Alexander Mauskop offering comprehensive headache and migraine treatment services since 1987. The center provides a unified approach combining FDA-approved treatments (Botox injections for chronic migraine, IV therapies) with innovative non-drug approaches (Transcranial Magnetic Stimulation, integrative medicine, complementary therapies including biofeedback and nutritional supplements). The practice treats both children and adults with a focus on safe, non-opioid solutions. Beyond clinical services, Dr. Mauskop has authored multiple books on migraine treatment including 'The End of Migraines: 150 Ways to Stop Your Pain' and medical textbooks for healthcare professionals.
Differentiator
Problem solved
Functional benefit
Products and services
- Headache and Migraine Treatment Services Comprehensive medical evaluation and treatment for headaches and migraines in both children and adults, providing safe, effective, and non-opioid solutions through proven medical treatments and innovative therapies.
- Botox Injections for Chronic Migraine FDA-approved onabotulinumtoxinA injections for chronic migraine headaches, administered using the 31-site, 155-unit per-session protocol, achieving positive results in approximately 70% of headache sufferers.
- Transcranial Magnetic Stimulation (TMS) Non-drug treatment for migraines and neurological conditions guided by advanced brain imaging (fMRI) for precision targeting of neural pathways.
- Intravenous (IV) Therapies In-office IV infusion treatments including magnesium, ketorolac (Toradol), metoclopramide (Reglan), ondansetron (Zofran), dihydroergotamine (DHE-45), dexamethasone (Decadron), Vyepti, and other medications for acute migraine and cluster headache relief.
- Nerve Blocks and Sphenopalatine Ganglion (SPG) Blocks Targeted nerve block injections, including sphenopalatine ganglion (SPG) blocks, used to relieve headache and migraine pain.
- Integrative Headache Medicine Program A blended program of traditional medicine and functional, complementary, or alternative therapies including biofeedback, meditation, and nutritional supplements such as magnesium, CoQ10, riboflavin, and feverfew, designed to address the root causes of headaches and migraines.
- Sumatriptan Injections Migraine-specific abortive therapy administered via subcutaneous injection for acute migraine relief.
- The End of Migraines: 150 Ways to Stop Your Pain Best-selling consumer book on migraine treatment authored by Dr. Alexander Mauskop, with three editions (2021, 2022, 2026) covering the latest advances in migraine treatment, five new drugs, a promising supplement, and expanded chapters; available on Amazon.com.
- The Headache Alternative: A Neurologist's Guide to Drug-Free Relief Consumer health book by Dr. Alexander Mauskop published by Dell offering drug-free approaches to headache relief.
- What Your Doctor May Not Tell You About Migraines Consumer health book by Dr. Alexander Mauskop published by Warner Books presenting a breakthrough program to help end migraine pain.
- Migraine and Headache (Oxford University Press) Two editions of a medical textbook for physicians published by Oxford University Press, authored by Dr. Alexander Mauskop, providing clinical reference material on migraine and headache treatment.
Quantifiable outcome
- Botox treatments achieve positive results in approximately 70% of headache sufferers
- +2 more outcomes
Companies that use New York Headache Center
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
New York Headache Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
New York Headache Center partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- AllergancoreDr. Mauskop visited Allergan's Botox manufacturing plant in Ireland with colleagues from Harvard, Mayo Clinic, and Barrow Neurological Institute, indicating a close professional relationship with the Botox manufacturer.
- Weill Cornell Medical CollegeminorDr. Mauskop presented the Dr. John J. Bonica Award to Dr. Richard Lipton at an EPA meeting, indicating ongoing academic collaboration.
- Charité BerlinminorMet with Prof. Uwe Reuter and Dr. Zoltan Medgyessy at Charité's Psychiatric and Neurologic Clinic in Berlin, indicating international academic collaboration.
- Israeli Headache AssociationminorMet with Dr. Oved Daniel, President of the Israeli Headache Association, indicating international professional networking and potential referral relationships.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
New York Headache Center competitors and assessment
Company assessmentRegional players
- Montefiore Headache Center: Hospital-based headache center in the Bronx, NY, offering specialized headache treatment within the Montefiore Health System. Comparable to NYHC as a New York-area headache specialty center, though operating within an academic hospital system rather than as an independent private practice.
Broad incumbents
- Cleveland Clinic Headache & Facial Pain Center: Multi-specialty hospital headache program offering Botox, nerve blocks, and integrative therapies. Comparable to NYHC in treatment modalities and patient population, but embedded in a large health system rather than operating as an independent specialty practice.
- Mass General Brigham Neurology / John R. Graham Headache Center: Academic headache center within the Mass General Brigham system providing advanced headache treatment and clinical trials. Comparable to NYHC as a destination for complex headache cases, but with the scale and insurance leverage of a major hospital network.
- Mayo Clinic Neurology / Headache Division: Large academic medical center with a dedicated headache division offering advanced diagnostics, Botox, nerve blocks, and clinical trials. Comparable to NYHC as a destination for refractory headache care, but operating at far greater scale and breadth within a multi-specialty hospital system.
- Stanford Headache Clinic: Academic headache program within Stanford Health Care offering advanced headache treatment and clinical research. Comparable to NYHC in delivering specialized headache medicine with a research/clinical interface, though operating at larger scale within a university system.
Direct peers
- Diamond Headache Clinic: Long-established private headache specialty clinic in Chicago founded in 1988, offering inpatient and outpatient headache treatment with a multi-physician team. Directly comparable to NYHC as a privately operated, founder-led headache specialty practice serving referral patients nationally.
- Jefferson Headache Center: Academic headache center at Thomas Jefferson University in Philadelphia, providing multidisciplinary headache and migraine care with neurology specialists. Comparable to NYHC as a specialized headache treatment destination with fellowship-trained neurologists and advanced procedural offerings.
- Michigan Headache & Neurological Institute: Specialty headache clinic in Ann Arbor, Michigan, providing outpatient headache and migraine treatment. Comparable to NYHC as a dedicated headache-focused neurology practice treating refractory cases through advanced procedures and integrative therapies.
Others
- Allergan (AbbVie) - Botox for Migraine: Manufacturer of onabotulinumtoxinA (Botox) indicated for chronic migraine. Related to NYHC through Dr. Mauskop's role as an early adopter and trainer of Botox for headaches since 1992, making Allergan a key ecosystem partner rather than a direct competitor.
Emerging players
- Cefaly: Medical device company offering FDA-cleared external trigeminal nerve stimulation devices for migraine prevention and acute treatment. Comparable to NYHC as an ecosystem player in non-pharmacological migraine treatment, though operating as a device manufacturer rather than a clinical practice.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
New York Headache Center social profiles
Digital presenceNew York Headache Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
New York Headache Center leadership team
Management profileNumber of profiles
Profiles7 records
New York Headache Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
New York Headache Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about New York Headache Center
What does New York Headache Center do?
New York Headache Center provides specialized medical care for the diagnosis and treatment of headaches and migraines in children and adults, offering integrative, non-opioid solutions including Botox injections, IV infusions, TMS, nerve blocks, and complementary therapies delivered at its Manhattan office and via telemedicine.
Is New York Headache Center a public or private company?
New York Headache Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was New York Headache Center founded?
New York Headache Center was founded in 1987. It employs 11 to 50 people.
Where is New York Headache Center based?
New York Headache Center is headquartered in New York, United States, in the North America region.
How does New York Headache Center make money?
Two revenue lines are on record. Medical Consultation and Treatment Services are the primary driver. The others are book Sales and Publications.
Who are New York Headache Center's main competitors?
Montefiore Headache Center is listed as a regional player. Broad incumbents are Cleveland Clinic Headache & Facial Pain Center, Mass General Brigham Neurology / John R. Graham Headache Center, Mayo Clinic Neurology / Headache Division and Stanford Headache Clinic. Direct peers are Diamond Headache Clinic, Jefferson Headache Center and Michigan Headache & Neurological Institute. Allergan (AbbVie) - Botox for Migraine is listed as an others. Cefaly is listed as an emerging player.
Does New York Headache Center have an API?
No public API is recorded for New York Headache Center.
What industry is New York Headache Center in?
New York Headache Center's product category is Specialty Neurology / Headache Medicine Services. Its primary akta.pro industry code is HLAKAIAE, Headache & Migraine Medicine, with a secondary code of HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 621111 and its SIC code is 8011.